 | • レポートコード：D0804-14933 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、106ページ • 納品方法：Eメール • 産業分類：医療機器・医療消耗品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、バイオセラピューティクス細胞株の世界市場を広く調査・分析し、今後の市場展望をまとめております。バイオセラピューティクス細胞株の種類別市場規模（シングルセルクローニング、トランスフェクション、セレクション）、用途別市場規模（がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Becton Dickinson、Partec、CMC Biologics、Beckman Coulter、ProBioGen、Boehringer Ingelheim Pharma、Sony Biotechnology、Lonza Group、Catalent、SAFC、Selexis、Thermo Fisher Scientific ・地域別グローバル市場分析 2015年-2020年 ・バイオセラピューティクス細胞株の北米市場（アメリカ、カナダ、メキシコ） ・バイオセラピューティクス細胞株のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・バイオセラピューティクス細胞株のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・バイオセラピューティクス細胞株の南米市場（ブラジル、アルゼンチン） ・バイオセラピューティクス細胞株の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：シングルセルクローニング、トランスフェクション、セレクション ・用途別分析：がん、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Biotherapeutics Cell Line market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.0% in the forecast period of 2020 to 2025 and will expected to reach USD 70 million by 2025, from USD 53 million in 2019.
The Biotherapeutics Cell Line market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Biotherapeutics Cell Line market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biotherapeutics Cell Line market has been segmented into:
Single Cell Cloning
Transfection and Selection
By Application, Biotherapeutics Cell Line has been segmented into:
Cancer
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biotherapeutics Cell Line market presented in the report. This section sheds light on the sales growth of different regional and country-level Biotherapeutics Cell Line markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biotherapeutics Cell Line market.
The report offers in-depth assessment of the growth and other aspects of the Biotherapeutics Cell Line market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Biotherapeutics Cell Line Market Share Analysis
Biotherapeutics Cell Line competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biotherapeutics Cell Line sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biotherapeutics Cell Line sales, revenue and market share for each player covered in this report.
The major players covered in Biotherapeutics Cell Line are:
Becton Dickinson
Partec
CMC Biologics
Beckman Coulter
ProBioGen
Boehringer Ingelheim Pharma
Sony Biotechnology
Lonza Group
Catalent
SAFC
Selexis
Thermo Fisher Scientific
Table of Contents
1 Biotherapeutics Cell Line Market Overview
1.1 Product Overview and Scope of Biotherapeutics Cell Line
1.2 Classification of Biotherapeutics Cell Line by Type
1.2.1 Global Biotherapeutics Cell Line Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Biotherapeutics Cell Line Revenue Market Share by Type in 2019
1.2.3 Single Cell Cloning
1.2.4 Transfection and Selection
1.3 Global Biotherapeutics Cell Line Market by Application
1.3.1 Overview: Global Biotherapeutics Cell Line Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer
1.3.3 Other
1.4 Global Biotherapeutics Cell Line Market by Regions
1.4.1 Global Biotherapeutics Cell Line Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Biotherapeutics Cell Line (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Biotherapeutics Cell Line Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Biotherapeutics Cell Line Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biotherapeutics Cell Line Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Biotherapeutics Cell Line Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biotherapeutics Cell Line Status and Prospect (2015-2025)
2 Company Profiles
2.1 Becton Dickinson
2.1.1 Becton Dickinson Details
2.1.2 Becton Dickinson Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Becton Dickinson SWOT Analysis
2.1.4 Becton Dickinson Product and Services
2.1.5 Becton Dickinson Biotherapeutics Cell Line Revenue, Gross Margin and Market Share (2018-2019)
2.2 Partec
2.2.1 Partec Details
2.2.2 Partec Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Partec SWOT Analysis
2.2.4 Partec Product and Services
2.2.5 Partec Biotherapeutics Cell Line Revenue, Gross Margin and Market Share (2018-2019)
2.3 CMC Biologics
2.3.1 CMC Biologics Details
2.3.2 CMC Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 CMC Biologics SWOT Analysis
2.3.4 CMC Biologics Product and Services
2.3.5 CMC Biologics Biotherapeutics Cell Line Revenue, Gross Margin and Market Share (2018-2019)
2.4 Beckman Coulter
2.4.1 Beckman Coulter Details
2.4.2 Beckman Coulter Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Beckman Coulter SWOT Analysis
2.4.4 Beckman Coulter Product and Services
2.4.5 Beckman Coulter Biotherapeutics Cell Line Revenue, Gross Margin and Market Share (2018-2019)
2.5 ProBioGen
2.5.1 ProBioGen Details
2.5.2 ProBioGen Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 ProBioGen SWOT Analysis
2.5.4 ProBioGen Product and Services
2.5.5 ProBioGen Biotherapeutics Cell Line Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boehringer Ingelheim Pharma
2.6.1 Boehringer Ingelheim Pharma Details
2.6.2 Boehringer Ingelheim Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Boehringer Ingelheim Pharma SWOT Analysis
2.6.4 Boehringer Ingelheim Pharma Product and Services
2.6.5 Boehringer Ingelheim Pharma Biotherapeutics Cell Line Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sony Biotechnology
2.7.1 Sony Biotechnology Details
2.7.2 Sony Biotechnology Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sony Biotechnology SWOT Analysis
2.7.4 Sony Biotechnology Product and Services
2.7.5 Sony Biotechnology Biotherapeutics Cell Line Revenue, Gross Margin and Market Share (2018-2019)
2.8 Lonza Group
2.8.1 Lonza Group Details
2.8.2 Lonza Group Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Lonza Group SWOT Analysis
2.8.4 Lonza Group Product and Services
2.8.5 Lonza Group Biotherapeutics Cell Line Revenue, Gross Margin and Market Share (2018-2019)
2.9 Catalent
2.9.1 Catalent Details
2.9.2 Catalent Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Catalent SWOT Analysis
2.9.4 Catalent Product and Services
2.9.5 Catalent Biotherapeutics Cell Line Revenue, Gross Margin and Market Share (2018-2019)
2.10 SAFC
2.10.1 SAFC Details
2.10.2 SAFC Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 SAFC SWOT Analysis
2.10.4 SAFC Product and Services
2.10.5 SAFC Biotherapeutics Cell Line Revenue, Gross Margin and Market Share (2018-2019)
2.11 Selexis
2.11.1 Selexis Details
2.11.2 Selexis Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Selexis SWOT Analysis
2.11.4 Selexis Product and Services
2.11.5 Selexis Biotherapeutics Cell Line Revenue, Gross Margin and Market Share (2018-2019)
2.12 Thermo Fisher Scientific
2.12.1 Thermo Fisher Scientific Details
2.12.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Thermo Fisher Scientific SWOT Analysis
2.12.4 Thermo Fisher Scientific Product and Services
2.12.5 Thermo Fisher Scientific Biotherapeutics Cell Line Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Biotherapeutics Cell Line Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Biotherapeutics Cell Line Players Market Share
3.2.2 Top 10 Biotherapeutics Cell Line Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Biotherapeutics Cell Line Revenue and Market Share by Regions
4.2 North America Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
4.3 Europe Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
4.5 South America Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
5 North America Biotherapeutics Cell Line Revenue by Countries
5.1 North America Biotherapeutics Cell Line Revenue by Countries (2015-2020)
5.2 USA Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
5.3 Canada Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
5.4 Mexico Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
6 Europe Biotherapeutics Cell Line Revenue by Countries
6.1 Europe Biotherapeutics Cell Line Revenue by Countries (2015-2020)
6.2 Germany Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
6.3 UK Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
6.4 France Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
6.5 Russia Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
6.6 Italy Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Biotherapeutics Cell Line Revenue by Countries
7.1 Asia-Pacific Biotherapeutics Cell Line Revenue by Countries (2015-2020)
7.2 China Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
7.3 Japan Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
7.4 Korea Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
7.5 India Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
8 South America Biotherapeutics Cell Line Revenue by Countries
8.1 South America Biotherapeutics Cell Line Revenue by Countries (2015-2020)
8.2 Brazil Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
8.3 Argentina Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Biotherapeutics Cell Line by Countries
9.1 Middle East & Africa Biotherapeutics Cell Line Revenue by Countries (2015-2020)
9.2 Saudi Arabia Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
9.3 UAE Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
9.4 Egypt Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
9.5 South Africa Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Biotherapeutics Cell Line Revenue and Market Share by Type (2015-2020)
10.2 Global Biotherapeutics Cell Line Market Forecast by Type (2019-2024)
10.3 Single Cell Cloning Revenue Growth Rate (2015-2025)
10.4 Transfection and Selection Revenue Growth Rate (2015-2025)
11 Global Biotherapeutics Cell Line Market Segment by Application
11.1 Global Biotherapeutics Cell Line Revenue Market Share by Application (2015-2020)
11.2 Biotherapeutics Cell Line Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2015-2020)
11.4 Other Revenue Growth (2015-2020)
12 Global Biotherapeutics Cell Line Market Size Forecast (2021-2025)
12.1 Global Biotherapeutics Cell Line Market Size Forecast (2021-2025)
12.2 Global Biotherapeutics Cell Line Market Forecast by Regions (2021-2025)
12.3 North America Biotherapeutics Cell Line Revenue Market Forecast (2021-2025)
12.4 Europe Biotherapeutics Cell Line Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Biotherapeutics Cell Line Revenue Market Forecast (2021-2025)
12.6 South America Biotherapeutics Cell Line Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Biotherapeutics Cell Line Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Biotherapeutics Cell Line Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biotherapeutics Cell Line by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biotherapeutics Cell Line Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Biotherapeutics Cell Line Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Becton Dickinson Corporate Information, Location and Competitors
Table 6. Becton Dickinson Biotherapeutics Cell Line Major Business
Table 7. Becton Dickinson Biotherapeutics Cell Line Total Revenue (USD Million) (2017-2018)
Table 8. Becton Dickinson SWOT Analysis
Table 9. Becton Dickinson Biotherapeutics Cell Line Product and Solutions
Table 10. Becton Dickinson Biotherapeutics Cell Line Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Partec Corporate Information, Location and Competitors
Table 12. Partec Biotherapeutics Cell Line Major Business
Table 13. Partec Biotherapeutics Cell Line Total Revenue (USD Million) (2018-2019)
Table 14. Partec SWOT Analysis
Table 15. Partec Biotherapeutics Cell Line Product and Solutions
Table 16. Partec Biotherapeutics Cell Line Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. CMC Biologics Corporate Information, Location and Competitors
Table 18. CMC Biologics Biotherapeutics Cell Line Major Business
Table 19. CMC Biologics Biotherapeutics Cell Line Total Revenue (USD Million) (2017-2018)
Table 20. CMC Biologics SWOT Analysis
Table 21. CMC Biologics Biotherapeutics Cell Line Product and Solutions
Table 22. CMC Biologics Biotherapeutics Cell Line Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Beckman Coulter Corporate Information, Location and Competitors
Table 24. Beckman Coulter Biotherapeutics Cell Line Major Business
Table 25. Beckman Coulter Biotherapeutics Cell Line Total Revenue (USD Million) (2017-2018)
Table 26. Beckman Coulter SWOT Analysis
Table 27. Beckman Coulter Biotherapeutics Cell Line Product and Solutions
Table 28. Beckman Coulter Biotherapeutics Cell Line Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. ProBioGen Corporate Information, Location and Competitors
Table 30. ProBioGen Biotherapeutics Cell Line Major Business
Table 31. ProBioGen Biotherapeutics Cell Line Total Revenue (USD Million) (2017-2018)
Table 32. ProBioGen SWOT Analysis
Table 33. ProBioGen Biotherapeutics Cell Line Product and Solutions
Table 34. ProBioGen Biotherapeutics Cell Line Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Boehringer Ingelheim Pharma Corporate Information, Location and Competitors
Table 36. Boehringer Ingelheim Pharma Biotherapeutics Cell Line Major Business
Table 37. Boehringer Ingelheim Pharma Biotherapeutics Cell Line Total Revenue (USD Million) (2017-2018)
Table 38. Boehringer Ingelheim Pharma SWOT Analysis
Table 39. Boehringer Ingelheim Pharma Biotherapeutics Cell Line Product and Solutions
Table 40. Boehringer Ingelheim Pharma Biotherapeutics Cell Line Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Sony Biotechnology Corporate Information, Location and Competitors
Table 42. Sony Biotechnology Biotherapeutics Cell Line Major Business
Table 43. Sony Biotechnology Biotherapeutics Cell Line Total Revenue (USD Million) (2017-2018)
Table 44. Sony Biotechnology SWOT Analysis
Table 45. Sony Biotechnology Biotherapeutics Cell Line Product and Solutions
Table 46. Sony Biotechnology Biotherapeutics Cell Line Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Lonza Group Corporate Information, Location and Competitors
Table 48. Lonza Group Biotherapeutics Cell Line Major Business
Table 49. Lonza Group Biotherapeutics Cell Line Total Revenue (USD Million) (2017-2018)
Table 50. Lonza Group SWOT Analysis
Table 51. Lonza Group Biotherapeutics Cell Line Product and Solutions
Table 52. Lonza Group Biotherapeutics Cell Line Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Catalent Corporate Information, Location and Competitors
Table 54. Catalent Biotherapeutics Cell Line Major Business
Table 55. Catalent Biotherapeutics Cell Line Total Revenue (USD Million) (2017-2018)
Table 56. Catalent SWOT Analysis
Table 57. Catalent Biotherapeutics Cell Line Product and Solutions
Table 58. Catalent Biotherapeutics Cell Line Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. SAFC Corporate Information, Location and Competitors
Table 60. SAFC Biotherapeutics Cell Line Major Business
Table 61. SAFC Biotherapeutics Cell Line Total Revenue (USD Million) (2017-2018)
Table 62. SAFC SWOT Analysis
Table 63. SAFC Biotherapeutics Cell Line Product and Solutions
Table 64. SAFC Biotherapeutics Cell Line Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Selexis Corporate Information, Location and Competitors
Table 66. Selexis Biotherapeutics Cell Line Major Business
Table 67. Selexis Biotherapeutics Cell Line Total Revenue (USD Million) (2017-2018)
Table 68. Selexis SWOT Analysis
Table 69. Selexis Biotherapeutics Cell Line Product and Solutions
Table 70. Selexis Biotherapeutics Cell Line Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 72. Thermo Fisher Scientific Biotherapeutics Cell Line Major Business
Table 73. Thermo Fisher Scientific Biotherapeutics Cell Line Total Revenue (USD Million) (2017-2018)
Table 74. Thermo Fisher Scientific SWOT Analysis
Table 75. Thermo Fisher Scientific Biotherapeutics Cell Line Product and Solutions
Table 76. Thermo Fisher Scientific Biotherapeutics Cell Line Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Global Biotherapeutics Cell Line Revenue (Million USD) by Players (2015-2020)
Table 78. Global Biotherapeutics Cell Line Revenue Share by Players (2015-2020)
Table 79. Global Biotherapeutics Cell Line Revenue (Million USD) by Regions (2015-2020)
Table 80. Global Biotherapeutics Cell Line Revenue Market Share by Regions (2015-2020)
Table 81. North America Biotherapeutics Cell Line Revenue by Countries (2015-2020)
Table 82. North America Biotherapeutics Cell Line Revenue Market Share by Countries (2015-2020)
Table 83. Europe Biotherapeutics Cell Line Revenue (Million USD) by Countries (2015-2020)
Table 84. Asia-Pacific Biotherapeutics Cell Line Revenue (Million USD) by Countries (2015-2020)
Table 85. South America Biotherapeutics Cell Line Revenue by Countries (2015-2020)
Table 86. South America Biotherapeutics Cell Line Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Biotherapeutics Cell Line Revenue (Million USD) by Countries (2015-2020)
Table 88. Middle East and Africa Biotherapeutics Cell Line Revenue Market Share by Countries (2015-2020)
Table 89. Global Biotherapeutics Cell Line Revenue (Million USD) by Type (2015-2020)
Table 90. Global Biotherapeutics Cell Line Revenue Share by Type (2015-2020)
Table 91. Global Biotherapeutics Cell Line Revenue Forecast by Type (2021-2025)
Table 92. Global Biotherapeutics Cell Line Revenue by Application (2015-2020)
Table 93. Global Biotherapeutics Cell Line Revenue Share by Application (2015-2020)
Table 94. Global Biotherapeutics Cell Line Revenue Forecast by Application (2021-2025)
Table 95. Global Biotherapeutics Cell Line Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Biotherapeutics Cell Line Picture
Figure 2. Global Biotherapeutics Cell Line Revenue Market Share by Type in 2019
Figure 3. Single Cell Cloning Picture
Figure 4. Transfection and Selection Picture
Figure 5. Biotherapeutics Cell Line Revenue Market Share by Application in 2019
Figure 6. Cancer Picture
Figure 7. Other Picture
Figure 8. Global Biotherapeutics Cell Line Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Biotherapeutics Cell Line Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Biotherapeutics Cell Line Revenue Market Share in 2019
Figure 17. Global Top 10 Players Biotherapeutics Cell Line Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Biotherapeutics Cell Line Revenue Market Share by Regions (2015-2020)
Figure 21. Global Biotherapeutics Cell Line Revenue Market Share by Regions in 2018
Figure 22. North America Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 23. Europe Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 25. South America Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 27. North America Biotherapeutics Cell Line Revenue Market Share by Countries (2015-2020)
Figure 28. North America Biotherapeutics Cell Line Revenue Market Share by Countries in 2019
Figure 29. USA Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 30. Canada Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 32. Europe Biotherapeutics Cell Line Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Biotherapeutics Cell Line Revenue Market Share by Countries in 2019
Figure 34. Germany Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 35. UK Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 36. France Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 37. Russia Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 38. Italy Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Biotherapeutics Cell Line Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Biotherapeutics Cell Line Revenue Market Share by Countries in 2019
Figure 41. China Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 42. Japan Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 43. Korea Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 44. India Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 46. South America Biotherapeutics Cell Line Revenue Market Share by Countries (2015-2020)
Figure 47. South America Biotherapeutics Cell Line Revenue Market Share by Countries in 2019
Figure 48. Brazil Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Biotherapeutics Cell Line Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Biotherapeutics Cell Line Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 53. UAE Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Biotherapeutics Cell Line Revenue and Growth Rate (2015-2020)
Figure 56. Global Biotherapeutics Cell Line Revenue Share by Type (2015-2020)
Figure 57. Global Biotherapeutics Cell Line Revenue Share by Type in 2019
Figure 58. Global Biotherapeutics Cell Line Market Share Forecast by Type (2021-2025)
Figure 59. Global Single Cell Cloning Revenue Growth Rate (2015-2020)
Figure 60. Global Transfection and Selection Revenue Growth Rate (2015-2020)
Figure 61. Global Biotherapeutics Cell Line Revenue Share by Application (2015-2020)
Figure 62. Global Biotherapeutics Cell Line Revenue Share by Application in 2019
Figure 63. Global Biotherapeutics Cell Line Market Share Forecast by Application (2021-2025)
Figure 64. Global Cancer Revenue Growth Rate (2015-2020)
Figure 65. Global Other Revenue Growth Rate (2015-2020)
Figure 66. Global Biotherapeutics Cell Line Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Biotherapeutics Cell Line Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Biotherapeutics Cell Line Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Biotherapeutics Cell Line Revenue Market Forecast (2021-2025)
Figure 70. Europe Biotherapeutics Cell Line Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Biotherapeutics Cell Line Revenue Market Forecast (2021-2025)
Figure 72. South America Biotherapeutics Cell Line Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Biotherapeutics Cell Line Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
肛門がんの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Anal Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anal Cancer market report provide…- セルイオンインジケーターの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The Cell Ion Indicator market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- シングルセルシーケンスの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Single Cell Sequencing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Single Cell Sequencing…
- シングルセルシーケンスの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Single Cell Sequencing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Single Cell Sequencing…
- がん治療ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Therapeutic Cancer Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…